Toxoplasmosis Treatment Market Growth 2023
The report is valuable in highlighting business performance, product portfolio, and strategic moves of market players to showcase the competitive scenario.
PORTLAND, OREGON, UNITED STATES, May 25, 2023 /EINPresswire.com/ — Allied Market Research published a report, titled, “Toxoplasmosis Treatment Market by Type (Acquired Toxoplasmosis, Congenital Toxoplasmosis), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers): Global Opportunity Analysis and Industry Forecast, 2021-2031”. According to the report, the global Toxoplasmosis Treatment Market Size was Valued at USD 683.1 million in 2021 and is Projected to Garner USD 1.09 billion by 2031, registering a CAGR of 4.8% from 2022 to 2031.
Covid-19 Scenario
• The outbreak of the Covid-19 pandemic had a negative impact on the global toxoplasmosis treatment market, as it disrupted workflows in the health care sector across the world.
• The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care.
• There had been a significant decrease in demand for toxoplasmosis during the pandemic. The significant reduction in clinical trials for toxoplasmosis treatment, owing to strict government guidelines against COVID-19 hampered the market growth. Decline in hospitals visit, closing of borders, and confinement of the population affected the supply chains of these life-saving medical products in the toxoplasmosis treatment industry.
• However, the market has now been able to recover slowly and steadily.
𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/16016
𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐑𝐞𝐜𝐞𝐧𝐭 𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐓𝐨𝐱𝐨𝐩𝐥𝐚𝐬𝐦𝐨𝐬𝐢𝐬 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭?
Increase in awareness about foodborne illness, surge in government support for healthcare infrastructure, rise in parasitic infection, and upsurge in use of daraprim drug for the treatment of toxoplasmosis infections drive the growth of the global toxoplasmosis treatment market. However, side effects toxoplasmosis drugs such as toxic epidermal necrolysis, erythema multiforme, and hyperphenylalaninemina hinder the market growth. Moreover, rise in product launches for the treatment of toxoplasmosis disease is projected to provide the beneficial opportunities for toxoplasmosis treatment market growth.
𝐓𝐨𝐩 𝐓𝐨𝐱𝐨𝐩𝐥𝐚𝐬𝐦𝐨𝐬𝐢𝐬 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬: –
• Alvogen
• Dr Reddy’s Laboratories Ltd.
• Teva Pharmaceutical Industries Limited
• Vyera Pharmaceuticals LLC
• Mangalam Drugs and Organics Ltd.
• Oakrum Pharma
• Kaiser Permanente
• Zorish Healthcare Private Limited
• Omicron pharmaceuticals
• Manus Aktteva Biopharma LLP
𝐓𝐨𝐱𝐨𝐩𝐥𝐚𝐬𝐦𝐨𝐬𝐢𝐬 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐜𝐚𝐧 𝐛𝐞 𝐝𝐨𝐧𝐞 𝐛𝐚𝐬𝐞𝐝 𝐨𝐧 𝐬𝐞𝐯𝐞𝐫𝐚𝐥 𝐟𝐚𝐜𝐭𝐨𝐫𝐬, 𝐢𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠:
Based on type, the acquired toxoplasmosis segment held the highest market share in 2021, accounting for more than two-thirds of the global toxoplasmosis treatment market, and is estimated to maintain its leadership status throughout the forecast period. This is owing to rise in prevalence of acquired toxoplasmosis caused due to accidental consumption of oocysts. However, the congenital toxoplasmosis segment is projected to manifest the highest CAGR of 5.5% from 2022 to 2031, owing increase in cases of congenital toxoplasmosis.
Based on route of administration, the oral segment held the highest market share in 2021, accounting for more than two-thirds of the global toxoplasmosis treatment market, and is estimated to maintain its leadership status throughout the forecast period. The same segment is projected to manifest the highest CAGR of 5.0% from 2022 to 2031, owing to advantages associated with oral route such as more pre-determined doses, convenience, patient self-administration, and easy to administer.
Based on distribution channel, the hospital pharmacies segment accounted for the largest share in 2021, contributing to around half of the global toxoplasmosis treatment market, and is projected to maintain its lead position during the forecast period. This is owing to large number of patient visits to the hospital pharmacies. However, the online providers segment is expected to portray the largest CAGR of 6.3% from 2022 to 2031, owing to rise in digitalization around the globe.
Based on region, North America held the highest market share in terms of revenue in 2021, accounting for nearly two-fifths of the global toxoplasmosis treatment market, and is likely to dominate the market during the forecast period, owing to rise in cases of parasitic infection cause the toxoplasmosis disease. However, the Asia-Pacific region is expected to witness the fastest CAGR of 5.5% from 2022 to 2031. Increase in spending capabilities, owing to rise in awareness programs for toxoplasmosis disease.
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/16016
Our Market Research Solution Provides You Answer to Below Mentioned Question:
• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?
By Region Outlook
• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
David Correa
Allied Analytics LLP
+ 1-800-792-5285
email us here
